Pseudomonas infections in cystic fibrosis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology*; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity; D012137:Respiratory System / Q000382:microbiology
D000900:Anti-Bacterial Agents